Treatment of Chronic Traumatic Encephalopathy by NEUROSTILBENE

Post Reply
curncman
Posts: 1156
Joined: Fri Jun 26, 2020 8:27 am

Re: Treatment of Chronic Traumatic Encephalopathy by NEUROSTILBENE

Post by curncman »

TIm, Great information for all of us. Seems like after reading conclusion I get the impression that its leading to cure to ALHEIMERS disease which is next stage of CTE. Is it Possible for you to reposition the data for NEUROSTILBENE to prevent inflammation in the Brain post / present / Pre COVID-19 ? Also the Neurostilbene's characteristic of being passing through blood-brain barrier makes it STRONG CANDIDATE for prevention/relief to COVID-19 patients? thanks
Last edited by curncman on Sun Jul 12, 2020 10:54 am, edited 1 time in total.
User avatar
TimGDixon
Posts: 2632
Joined: Fri Jun 26, 2020 4:36 am

Re: Treatment of Chronic Traumatic Encephalopathy by NEUROSTILBENE

Post by TimGDixon »

Remember these are mouse and human cell models. But it's enough to go further and that means clinical trials. We'll get back to it. Plenty of work to do - but for now we have our plate full with covid-19 and what we are already doing.
curncman
Posts: 1156
Joined: Fri Jun 26, 2020 8:27 am

Re: Treatment of Chronic Traumatic Encephalopathy by NEUROSTILBENE

Post by curncman »

I think TSOI in Phase II we can easily beat and better than what ALTIMMUNE is currently getting ready to do with 800 patients in Phase III with FEDERAL GRANT of 4.7 million USD . No offense to their technology but I feel TSOI' products is much superior based on the data from the human/mouse pre clinical and pilot trial
Last edited by curncman on Sun Jul 12, 2020 11:23 am, edited 1 time in total.
trader32176
Posts: 3690
Joined: Fri Jun 26, 2020 5:22 am

Re: Treatment of Chronic Traumatic Encephalopathy by NEUROSTILBENE

Post by trader32176 »

Therapeutic Solutions International Reports Inhibition of Microglial Activation with NeuroStilbene

Recent Data Supports NeuroStilbene to Suppress Neural Inflammation, Induce Regeneration, and Protect Brain Cells from Death


https://www.prnewswire.com/news-release ... 83513.html

OCEANSIDE, California, Jan. 8, 2020 /PRNewswire/ -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) reported today positive animal and human brain cell data demonstrating inhibition in microglial activation of IL-1 beta, IL-6, and TNF-a. NeuroStilbene was also shown to induce neurogenic growth factors and protected from peroxide and kainic-acid induced apoptosis.

NeuroStilbene is a diluted preparation of NanoStilbene and will soon be available from WCTE, Inc. whom we have recently engaged in a multi-million-dollar sales agreement. NanoStilbene is a Patented and highly concentrated nanoemulsion of nanoparticle pterostilbene, the active ingredient contained in both formulations.

Chronic Traumatic Encephalopathy (CTE) is caused by repetitive concussive/sub-concussive hits to the head sustained over a period of years and is often found in football players. The condition is characterized by memory loss, impulsive/erratic behavior, impaired judgment, aggression, depression, and dementia. In many patients with CTE, it is anatomically characterized by brain atrophy, reduced mass of frontal and temporal cortices, and medial temporal lobe.

"This is very exciting data to see that NeuroStilbene administration in both animals and human cell lines preserves and stimulates the proliferation of endogenous neural stem cells under inflammatory conditions, while stimulating neurogenic growth factors: BDNF, NGF, FGF-1, FGF-2. To determine this, microglial were cultured with TNF-alpha to induce neurogenic growth factors for 48 hours in the presence of increasing concentrations of NeuroStilbene," said Dr. Thomas E. Ichim, Director.

"This data is phenomenal, and our Science Team is currently authoring the manuscript to be submitted for peer review as quickly as they can. We have now shown in these experiments that NeuroStilbene suppresses brain inflammation, protects brain neurons from death, stimulates the production of regenerative factors from microglial, and enhances the proliferation of endogenous brain stem cells at the same time at very low dosage," said Timothy G. Dixon, President, and CEO. "We continue to advance the cause of solving the CTE crisis while maximizing the potential of this little molecule pterostilbene that continues to deliver, welcome to 2020."
trader32176
Posts: 3690
Joined: Fri Jun 26, 2020 5:22 am

Re: Treatment of Chronic Traumatic Encephalopathy by NEUROSTILBENE

Post by trader32176 »

It's good to see this product is being offered for sale online !

https://www.wcteinc.org/product-page/neurostilbene

https://www.tivabio.com/collections/fro ... o-plus-cbd

This is a sleeper product . -imo , but Trader sees ahead into it's potential - cuz nobody else is still watching this product right now.


The ability of Neurostilbene to access the Blood Brain Barrier is part of this potential :


Therapeutic Solutions International, Inc., Releases Intranasal Formulation of Pterostilbene for Rapid Access to Blood-Brain Barrier

https://www.globenewswire.com/news-rele ... rrier.html


Terry LeCount, NFL pro football veteran of repeated concussions , has tried this product , and this is his testimony :


https://www.wcteinc.org/alzheimers
Post Reply